BDMCX | BGCKX | BDMCX / BGCKX | |
Total Expense Ratio | 2.34 | 1.29 | 181% |
Annual Report Gross Expense Ratio | 2.37 | 1.31 | 181% |
Fund Existence | 13 years | 10 years | - |
Gain YTD | 10.340 | 11.259 | 92% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.88B | 6.88B | 100% |
Annual Yield % from dividends | 10.29 | 9.94 | 104% |
Returns for 1 year | 12.42 | 13.65 | 91% |
Returns for 3 years | 55.27 | 60.24 | 92% |
Returns for 5 years | 52.39 | 60.80 | 86% |
Returns for 10 years | 42.95 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PXLIX | 14.34 | 0.06 | +0.42% |
Impax Large Cap Fund Institutional | |||
FIRAX | 10.33 | 0.01 | +0.10% |
Fidelity Advisor Intl Real Estate A | |||
GIRMX | 29.64 | -0.05 | -0.17% |
Goldman Sachs Emerging Markets Eq Inv | |||
BIPIX | 56.46 | -0.10 | -0.18% |
ProFunds Biotechnology UltraSector Inv | |||
MINJX | 45.87 | -0.31 | -0.67% |
MFS International Intrinsic Value R6 |